Profile and evolution of the chemosusceptibility of falciparum malaria imported into France in 2000 | Zendy

Pascal Ralaimazava | Zendy; Rémy Durand | Zendy; N. Godineau | Zendy; A Keundjian | Zendy; Z Jezic | Zendy; Bruno Pradines | Zendy; Olivier Bouchaud | Zendy; Jacques Le Bras | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Profile and evolution of the chemosusceptibility of falciparum malaria imported into France in 2000

Author(s) -

Pascal Ralaimazava,

Rémy Durand,

N. Godineau,

A Keundjian,

Z Jezic,

Bruno Pradines,

Olivier Bouchaud,

Jacques Le Bras

Publication year - 2002

Publication title -

eurosurveillance

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.766

H-Index - 104

eISSN - 1560-7917

pISSN - 1025-496X

DOI - 10.2807/esm.07.07.00355-en

Subject(s) - malaria , quinine , mefloquine , plasmodium falciparum , chloroquine , virology , drug resistance , first line , medicine , biology , immunology , microbiology and biotechnology

In 2000, the chemosusceptibility of imported malaria was stable in France. All countries of infection considered, the bi-resistance to chloroquine and cycloguanil has not changed from 1996 to 2000. The monotherapy using quinine or mefloquine remains the first-line treatment to falciparum malaria. Resistance to these two antimalarials is rare in Africa and has not evolved over the past 15 years.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research